Acquisition Opportunity Inovet was acquired by Orion Corporation in June 2022 for approximately 130 million euros, indicating potential alignment with Orion’s distribution networks and veterinary portfolio for cross-sell and co-marketing opportunities.

Global Footprint With divisions in Belgium, France, Hungary, and Vietnam and worldwide operations, there is potential to expand distribution of Inovet products through existing Orion channels and leverage regional demand in Europe and Asia.

Product Portfolio Over 220 products and 1,200 international marketing authorizations across antibiotics, chemotherapeutics, vitamins, anti-parasitics, and more, offering multiple entry points for new formulations, toll manufacturing, and private-label collaborations.

Manufacturing Capabilities A dedicated French production facility with multiple units for injectables, oral solutions, powders, and complementary feeds, presenting opportunities for contract manufacturing, white-label partnerships, and expansion of livestock-focused product lines.

Market Focus Active in global veterinary segments including livestock and poultry, with participation in industry events and a history of launching new products, suggesting readiness for targeted sales campaigns to large animal health markets and regional distributors.